참고문헌
- Chen CH, Lin YS, Lin CC, et al (2004). Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. J Oral Pathol Med, 33, 89-94.
- Chen CH, Tsai TL, Yang YS, Tsai CC (2007). Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma. J Oral Pathol Med, 36, 83-7. https://doi.org/10.1111/j.1600-0714.2007.00502.x
- Citri A, Yarden Y (2006). EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol, 7, 505-16.
- Cross M, Dexter TM (1991). Growth factors in development, transformation, and tumorigenesis. Cell, 64, 271-80. https://doi.org/10.1016/0092-8674(91)90638-F
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Fong Y, Chou SJ, Hung KF, Wu HT, Kao SY (2008). An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. J Chin Med Assoc, 71, 123-27. https://doi.org/10.1016/S1726-4901(08)70003-0
- Henning H, Robert G, Alexander G, et al (2014). Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas. J Oral Pathol Med, 43, 304-8. https://doi.org/10.1111/jop.12173
- Hou L, Shi D, Tu SM, et al (1992). Oral cancer progression and c-erbB-2/neu proto-oncogene expression. Cancer Lett, 65, 215-20. https://doi.org/10.1016/0304-3835(92)90234-M
- Ibrahim SO, Lillehaug JR, Johannessen AC, et al (1999). Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol, 35, 302-13. https://doi.org/10.1016/S1368-8375(98)00120-1
- Khan AJ, King BL, Smith BD, et al (2002). Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res, 8, 540-8.
- Li B, Wang M, Wen Y, Chen J (1992). Erb-B oncogene in human oral squamous cell carcinomas. Hua Xi Yi Ke Da Xue Xue Bao, 23, 284-87.
- Lutfiye D, Seyran Y, Canan S, et al (2014). Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype? Asian Pac J Cancer Prev, 15, 9739-45. https://doi.org/10.7314/APJCP.2014.15.22.9739
- Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA (2007). Molecular genetics of premalignant oral lesions. Oral Dis, 13, 126-33. https://doi.org/10.1111/j.1601-0825.2006.01349.x
- Pinto LS, de Aguiar FC Jr, Kowalski LP, Graner E, Lopes MA (2010). FAS and ErbB2 expression in early local recurrent oral cancer. J Oral Pathol Med, 39, 176-81. https://doi.org/10.1111/j.1600-0714.2009.00822.x
- Safoura S, Shahriar S, Kamran N, Behzad A (2009). Lack of Elevated HER2/neu Expression in Epithelial Dysplasia and Oral Squamous Cell Carcinoma in Iran. Asian Pacific J Cancer Prev, 10, 661-4.
- Schartinger VH, Kacani L, Andrle J, et al (2004). Pharmacodiagnostic value of the HER family in head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec, 66, 21-6. https://doi.org/10.1159/000077229
- Stoicanescu D, Andreescu N, Belengeanu A, Meszaros N, Cornianu M (2013). Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas. Rom J Morphol Embryol, 54, 1107-13.
- Tadokoro K, Ueda M, Ohshima T, et al (1989). Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc. Oncogene, 4, 499-505.
- Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG (2007). Advances in the biology of oral cancer. Oral Oncol, 43, 523-34. https://doi.org/10.1016/j.oraloncology.2006.11.010
- Vanessa FB, Frederico O, Silvia FS, et al (2010). Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study. J Exp Clin Cancer Res, 29, 40. https://doi.org/10.1186/1756-9966-29-40
- Werkmeister R, Brandt B, Joos U (1999). Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg, 37, 477-80. https://doi.org/10.1054/bjom.1999.0185
- Xia W, Lau YK, Zhang HZ, et al (1997). Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res, 3, 3-9.